Cement products and methods of making and using the same
Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component and a second component. The first component comprises a polymerizable resin comprising ethylenic unsaturated double bond, a suitable glycidyl group and/or a suitable isocyanate group. The second component includes a compound comprising more than one type of amine selected from the group consisting of primary amine, secondary amines, tertiary amines and quaternary amines. Alternatively, the second component includes a compound comprising a suitable mercapto (SH—) group, a hindered amine or a dimethylthiotoluenediamine (DMTDA). Optionally, the cement product includes a filler and/or a bioactive component to promote bone formation.
1. A injectable orthopedic cement product comprising:
a first component comprising trimethyloipropane benzoate diacrylate and pentaerythritol tetraacrylate; and
a second component comprising spermidine;
wherein the ratio of hydrogen donor equivalents to hydrogen acceptor equivalents is about 1:1;
wherein each of the first component and second component further comprise alpha-tricalcium phosphate having a particle size of 30 microns or less and wherein the amount of tricalcium phosphate is about 50% to about 80% by weight of the cement product.
2. An injectable orthopedic cement product comprising:
a first component comprising (a) a diacrylate resin and (b) a crosslinker selected from a tri-acrylate and tetra-acrylate; and
a second component comprising an aliphatic polyamine containing primary and secondary amine groups and not containing tertiary amine groups, wherein the ratio of primary to secondary amine groups in the aliphatic polyamine is greater than 1,
wherein the ratio of acceptor hydrogen equivalents to donor hydrogen equivalents is about 0.8:1 to about 1:1.2;
wherein each of the first component and second component is in the form of a liquid having a viscosity suitable for injection through a 4-18 gauge needle; and
wherein, when the first component and the second component are reacted together in a polymerization reaction at room temperature, they form a cement having a dry-to-touch finish within about 2 to about 25 minutes.
3. The cement product of claim 2 , wherein the cross-linker is a tri-acrylate or tetra-acrylate of pentaerythritol.
4. The cement product of claim 2 , wherein the ratio of primary to secondary amine group in the aliphatic polyamine is 2.
5. The cement product of claim 2 , wherein the polyamine is selected from the group consisting of triethylenetetramine, spermidine, spermine and combinations thereof.
6. An injectable orthopedic cement product comprising:
a first component comprising a multi-functional acrylate selected from the group consisting of ethoxylated (2) bisphenol A diacrylate, bisphenol A glycerolate (1-glycerol/phenol)diacrylate, diethyleneglycol diacrylate, dipropyleneglycol diacrylate, 1,3-butyleneglycol diacrylate, 1,4-butanediol diacrylate, 1,6-hexanediol diacrylate, trimethylolpropane benzoate diacrylate, glyceryl propoxy triacrylate, pentaerythritol triacrylate, pentaerythritol tetraacrylate, tris(2-hydroxyethyl)isocyanurate triacrylate, trimethylolpropane triacrylate, and mixtures thereof; and
a second component comprising a multifunctional polyamine selected from the group consisting of trans-1,2-diaminocyclohexane, 2-methyl-1,5-pentanediamine, spermidine, 1,4-diaminobutane, spermine, and mixtures thereof;
wherein the ratio of acceptor hydrogen equivalents to donor hydrogen equivalents is about 0.8:1 to about 1:1.2.
7. A ready to use kit comprising the cement product of claim 1 , wherein the kit comprises a dual chambered self-mixing syringe and wherein the first component is placed in a first chamber and the second component is placed in a second chamber.
8. A ready to use kit comprising the cement product of claim 2 , wherein the kit comprises a dual chambered self-mixing syringe and wherein the first component is placed in a first chamber and the second component is placed in a second chamber.
9. A ready to use kit comprising the cement product of claim 6 , wherein the kit comprises a dual chambered self-mixing syringe and wherein the first component is placed in a first chamber and the second component is placed in a second chamber.